| Literature DB >> 25415172 |
Kavita Shah Arora1, Monique Spillman, Magdy Milad.
Abstract
Intensive media and policy attention has been focused on the ongoing controversy surrounding uterine morcellation in gynecologic surgery. What has been missing from this impassioned discourse is an objective analysis of the ethical implications of uterine power morcellation in gynecologic surgery. This article discusses competing ethical duties of physicians, industry, the U.S. Food and Drug Administration, and the media to develop a more robust and nuanced understanding of informed consent for the use of morcellation in benign gynecologic surgery. Ultimately, as physicians, we must remain steadfast in our dedication to the use of evolving technologies to better patient health in a safe and ethical manner that is well-studied, informed, and implemented with appropriate training and precautions.Entities:
Mesh:
Year: 2014 PMID: 25415172 DOI: 10.1097/AOG.0000000000000525
Source DB: PubMed Journal: Obstet Gynecol ISSN: 0029-7844 Impact factor: 7.661